Similar response rates and survival with PARPi treatments for patients harboring somatic versus germline BRCA mutations: A meta-analysis and systematic review. Article

Mohyuddin, Ghulam Rehman, Aziz, Muhammad, Britt, Alec et al. (2020). Similar response rates and survival with PARPi treatments for patients harboring somatic versus germline BRCA mutations: A meta-analysis and systematic review. . JOURNAL OF CLINICAL ONCOLOGY, 38(15_suppl), e16802-e16802. 10.1200/jco.2020.38.15_suppl.e16802

cited authors

  • Mohyuddin, Ghulam Rehman; Aziz, Muhammad; Britt, Alec; Wade, Lee; Sun, Weijing; Baranda, Joaquina Celebre; Al-Rajabi, Raed Moh'd Taiseer; Saeed, Anwaar; Kasi, Anup

authors

publication date

  • May 20, 2020

published in

keywords

  • 3 Good Health and Well Being
  • 32 Biomedical and Clinical Sciences
  • 3202 Clinical Sciences
  • 3211 Oncology and Carcinogenesis
  • 6.1 Pharmaceuticals
  • Clinical Research
  • Clinical Trials and Supportive Activities
  • Genetics
  • Precision Medicine
  • Women's Health

Digital Object Identifier (DOI)

publisher

  • American Society of Clinical Oncology (ASCO)

start page

  • e16802

end page

  • e16802

volume

  • 38

issue

  • 15_suppl